|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Aging | |||||
| Hypogonadism | |||||
| Andropause | |||||
| 2 | More general conditions related to this trial | ||||
| Endocrine System Diseases | |||||
| Gonadal Disorders | |||||
| 3 | Interventions listed in this trial | ||||
| Anastrozole | |||||
| Testosterone Gel | |||||
| Placebo tablet | |||||
| Placebo gel | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Methyltestosterone | |||||
| Testosterone | |||||
| Testosterone 17 beta-cypionate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anabolic Agents | |||||
| Androgens | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Aromatase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||